Updated Jul 16, 2026
Spitznagel Thomas is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Thomas Spitznagel is the Senior Vice President of Technical Operations at Macrogenics Inc, a biotechnology company focused on developing antibody-based therapeutics for cancer treatment. He has been involved in the company's operations but does not appear to have a significant public profile.
| Role | Sr VP, Technical Ops |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-17 | MGNX | MACROGENICS INC | F — Tax withholding / forfeiture | 5.5K | $1.71 | $9K |
| 2026-02-17 | MGNX | MACROGENICS INC | M — Option exercise | 13.3K | — | |
| 2026-02-10 | MGNX | MACROGENICS INC | F — Tax withholding / forfeiture | 3.2K | $1.81 | $6K |
| 2026-02-10 | MGNX | MACROGENICS INC | M — Option exercise | 9.0K | — | |
| 2026-02-10 | MGNX | MACROGENICS INC | F — Tax withholding / forfeiture | 2.5K | $1.81 | $4K |
| 2026-02-10 | MGNX | MACROGENICS INC | M — Option exercise | 6.0K | — |
Thomas Spitznagel is the Senior Vice President of Technical Operations at Macrogenics Inc, a biotechnology company focused on developing antibody-based therapeutics for cancer treatment. He has been involved in the company's operations but does not appear to have a significant public profile.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Spitznagel Thomas profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.